Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (109)	8/14/2001 1:05:40 AM
From: tuck	Respond to of 598

>>WASHINGTON (CBS.MW) - Tularik Inc. registered to offer from time to time up to $250 million of debt securities and common stock, according to registration statement filed Monday with the Securities and Exchange Commission. The San Francisco-based pharmaceutical company said proceeds from the sale of securities are for research and development and general corporate purposes, according to the filing. The company also said it may use a portion of the net proceeds to acquire or invest in businesses, products and technologies. The company's (TLRK: news, chart, profile) shares fell 54 cents to $21.44.<< Cheers, Tuck